Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07285863 · ClinicalTrials.gov registry record · Phase 4
A Study Of Effect Of Secretin For In Injection (Chirostim) On Pancreatic Fluid Composition In Healthy Subjects
A Phase 4 study, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
NCT07285863: Recruiting Phase 4 study, sponsored by Mayo Clinic.
NCT07285863 is a Phase 4 study that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07285863, a Phase 4 study, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to collect pancreas fluid from the duodenum using the endoscopic pancreas function collection method in healthy participants after pancreatic stimulation with human secretin.
Interventions
- DRUG Secretin (human synthetic) - ChiRhoClin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2026-03-11 |
| Est. Completion | 2028-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07285863
The ClinicalTrials.gov registry entry for NCT07285863 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Secretin (human synthetic) - ChiRhoClin is the first listed.
NCT07285863 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07285863 about?
NCT07285863 is a clinical study titled "A Study Of Effect Of Secretin For In Injection (Chirostim) On Pancreatic Fluid Composition In Healthy Subjects". The purpose of this study is to collect pancreas fluid from the duodenum using the endoscopic pancreas function collection method in healthy participants after pancreatic stimulation with human secretin.
What is the current status of trial NCT07285863?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2026-03-11. Estimated completion is 2028-03.
What interventions are being tested in trial NCT07285863?
The interventions under investigation include: Secretin (human synthetic) - ChiRhoClin (DRUG).
Who is sponsoring clinical trial NCT07285863?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.